Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Human MET/c-Met/HGFR Nanobody (SAA1308)

Catalog #:   RHC34202 Specific References (27) DATASHEET
Host species: Alpaca
Isotype: VHH-8His-Cys-tag
Applications: ELISA, FCM
Expression system: Mammalian Cells
Overview

Catalog No.

RHC34202

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Alpaca

Isotype

VHH-8His-Cys-tag

Clonality

Monoclonal

Target

Tyrosine-protein kinase Met, Hepatocyte growth factor receptor, Proto-oncogene c-Met, Scatter factor receptor, HGF receptor, SF receptor, HGF/SF receptor, MET

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Purified by Nickel column.

Accession

P08581

Applications

ELISA, FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA1308

Data Image
  • SDS-PAGE
    SDS PAGE for Human MET/c-Met/HGFR Nanobody
References

Q-TWiST Analysis of Sacituzumab Govitecan vs. Chemotherapy in Previously Treated Patients with HR+/HER2- Metastatic Breast Cancer., PMID:40136373

Cysteine-selective [188Re]Re(v) radiolabelling of a Nanobody® for targeted radionuclide therapy using a "chelate-then-click" approach., PMID:40078611

Antitumor Activity of a Bispecific Chimera Targeting EGFR and Met in Gefitinib-Resistant Non-Small Cell Lung Cancer., PMID:39586988

Evaluation of a Novel MET-Targeting Camelid-Derived Antibody in Head and Neck Cancer., PMID:39513517

Autoinhibition of dimeric NINJ1 prevents plasma membrane rupture., PMID:39476863

Dual-Targeting of the HER2 Cancer Receptor with an Antibody-Directed Enzyme and a Nanobody-Guided MMAE Prodrug Scaffold., PMID:38945824

Nanobody-mediated targeting of zinc phthalocyanine with polymer micelles as nanocarriers., PMID:38492899

Development of an Engineered Single-Domain Antibody for Targeting MET in Non-Small Cell Lung Cancer., PMID:38470611

Biparatopic Nanobody-Based Immunosorbent for the Highly Selective Elimination of Tumor Necrosis Factor-α., PMID:38364210

Bispecific Nanobody-Aptamer Conjugates for Enhanced Cancer Therapy in Solid Tumors., PMID:38225704

Optimizing expression of Nanobody® molecules in Pichia pastoris through co-expression of auxiliary proteins under methanol and methanol-free conditions., PMID:37481525

The Impact of Nanobody Density on the Targeting Efficiency of PEGylated Liposomes., PMID:36499301

Biological treatment for erythrodermic psoriasis., PMID:36154361

Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumors., PMID:36108560

Outlook of therapeutic and diagnostic competency of nanobodies against SARS-CoV-2: A systematic review., PMID:34995616

Therapeutic Nanobodies Targeting Cell Plasma Membrane Transport Proteins: A High-Risk/High-Gain Endeavor., PMID:33418902

VHH-Photosensitizer Conjugates for Targeted Photodynamic Therapy of Met-Overexpressing Tumor Cells., PMID:31544832

Anti-MET VHH Pool Overcomes MET-Targeted Cancer Therapeutic Resistance., PMID:30361332

Structural basis of VHH-mediated neutralization of the food-borne pathogen Listeria monocytogenes., PMID:29976754

Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacy., PMID:27546726

In situ proteolysis, crystallization and preliminary X-ray diffraction analysis of a VHH that binds listeria internalin B., PMID:25372824

Targeting hepatocyte growth factor receptor (Met) positive tumor cells using internalizing nanobody-decorated albumin nanoparticles., PMID:24139763

Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment., PMID:23952536

Design and selection of a camelid single-chain antibody yeast two-hybrid library produced de novo for the cap protein of porcine circovirus type 2 (PCV2)., PMID:23469171

Nanobodies targeting the hepatocyte growth factor: potential new drugs for molecular cancer therapy., PMID:22319202

Toward chaperone-assisted crystallography: protein engineering enhancement of crystal packing and X-ray phasing capabilities of a camelid single-domain antibody (VHH) scaffold., PMID:18445622

Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies., PMID:16095608

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human MET/c-Met/HGFR Nanobody (SAA1308) [RHC34202]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only